Prima BioMed Ltd Shareholders' Briefing Webcast & Dial In Details

SYDNEY, AUSTRALIA--(Marketwire -06/12/12)- Prima BioMed Ltd (PRR.AX) (PBMD) confirms the webcast and dial in details for the shareholder briefing to be held on Friday 15th June 2012, at 9:30am (Sydney time).

Webcast link

Shareholders who are unable to attend the meeting and wish to view the proceedings on the Webcast should use the following link:

http://events.knowledgevision.com/staging/The_Prima_Biomed_Shareholder_Briefing.html

Shareholders who would also like to ask a question at the meeting are requested to dial in on one of the following numbers:

Dial in Numbers:

 
Australia Toll Free                1 800 131 617
Australia Alternate Toll Free      1 800 838 758
Canada/USA                         1 855 624 0077
China Wide                         10 800 140 1776
France                             0800 913 734
Germany                            0800 183 0918
Hong Kong                          0800 968 273
India                              0008 0010 08070
Indonesia                          001 803 321 8057
Ireland                            1800 948 607
Japan                              006633 868000
Malaysia                           1800 816 441
New Zealand                        0800 452 795
Singapore                          800 101 2702
South Africa                       0800 984 013
Switzerland                        0800 802 498
Taiwan                             0080 112 7377
UAE                                8000 3570 2706
United Kingdom                     0800 051 1453

About Prima BioMed

Prima BioMed is a global biotechnology company headquartered in Australia. As a leader in personalized bio-therapeutic products for cancer, Prima is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. Prima's lead product is CVac™, an autologous dendritic cell product currently in clinical trials for ovarian cancer.